<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined antepartum clinical characteristics along with measures of <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, insulin sensitivity, pancreatic beta-cell function, and body composition in Latino women with <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) for their ability to predict type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) within 6 months after delivery </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 122 islet cell antibody-negative women underwent oral and intravenous <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance tests (OGTT; IVGTT), hyperinsulinemic-euglycemic clamps, and measurement of body fat between 29 and 36 weeks' gestation and returned between 1 and 6 months postpartum for a 75-g OGTT </plain></SENT>
<SENT sid="2" pm="."><plain>Logistic regression analysis was used to examine the relationship between antepartum variables and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status postpartum </plain></SENT>
<SENT sid="3" pm="."><plain>At postpartum testing, 40% of the cohort had <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, 50% had IGT, and 10% had <z:mp ids='MP_0002055'>diabetes</z:mp> by American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association criteria </plain></SENT>
<SENT sid="4" pm="."><plain>Independent antepartum predictors of postpartum <z:mp ids='MP_0002055'>diabetes</z:mp> were the 30-min incremental insulin:<z:chebi fb="105" ids="17234">glucose</z:chebi> ratio during a 75-g OGTT (P = 0.0002) and the total area under the diagnostic 100-g <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance curve (P = 0.003) </plain></SENT>
<SENT sid="5" pm="."><plain>Independent predictors of postpartum IGT were a low first-phase IVGTT insulin response (P = 0.0001), a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> before 22 weeks' gestation (P = 0.003), and <z:mp ids='MP_0005456'>weight gain</z:mp> between prepregnancy and the postpartum examination (P = 0.03) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects had low insulin sensitivity during <z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">late pregnancy</z:e>, but neither <z:chebi fb="105" ids="17234">glucose</z:chebi> clamp nor minimal model measures of insulin sensitivity in the 3rd trimester were associated with the risk of IGT or <z:mp ids='MP_0002055'>diabetes</z:mp> within 6 months' postpartum </plain></SENT>
<SENT sid="7" pm="."><plain>These results highlight the importance of pancreatic <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo>, detectable under conditions of marked <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">late pregnancy</z:e>, to predict abnormalities of <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance soon after delivery in pregnancies complicated by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, the association of postpartum IGT with <z:mp ids='MP_0005456'>weight gain</z:mp> and an early gestational age at diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> suggests a role for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in mediating <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> outside the 3rd trimester in women with such a beta-cell defect </plain></SENT>
</text></document>